Home/Filings/4/0001217747-12-000008
4//SEC Filing

Blakeley John 4

Accession 0001217747-12-000008

CIK 0001026650other

Filed

Feb 28, 7:00 PM ET

Accepted

Feb 29, 5:53 PM ET

Size

19.7 KB

Accession

0001217747-12-000008

Insider Transaction Report

Form 4
Period: 2012-02-27
Blakeley John
Exec V.P., Sales & Marketing
Transactions
  • Tax Payment

    Common Stock, $.01 par value

    2012-02-27$5.79/sh1,084$6,27625,192 total
  • Award

    Common Stock, $.01 par value

    2012-02-28+14,87940,071 total
  • Award

    Option (Right to Buy)

    2012-02-28$6.49/sh+30,366$197,07530,366 total
    Exercise: $6.49Exp: 2019-02-28Common Stock, $.01 par value (30,366 underlying)
Holdings
  • Option (Right to Buy)

    Exercise: $6.46Exp: 2018-03-02Common Stock, $.01 par value (30,340 underlying)
    30,340
  • Option (Right to Buy)

    Exercise: $6.05Exp: 2017-02-26Common Stock, $.01 par value (26,895 underlying)
    26,895
  • Option (Right to Buy)

    Exercise: $4.60Exp: 2016-03-02Common Stock, $.01 par value (50,000 underlying)
    50,000
  • Option (Right to Buy)

    Exercise: $12.00Exp: 2015-02-28Common Stock, $.01 par value (25,000 underlying)
    25,000
  • Option (Right to Buy)

    Exercise: $7.41Exp: 2014-02-23Common Stock, $.01 par value (20,000 underlying)
    20,000
  • Option (Right to Buy)

    Exercise: $14.70Exp: 2013-02-10Common Stock, $.01 par value (5,000 underlying)
    5,000
  • Options (Right to Buy)

    Exercise: $22.09Exp: 2014-02-09Common Stock, $.01 par value (300 underlying)
    300
  • Option (Right to Buy)

    Exercise: $3.01Exp: 2012-07-23Common Stock, $.01 par value (2,025 underlying)
    2,025
Footnotes (4)
  • [F1]Represents a restricted stock grant that vests in four equal annual installments beginning one year after date of grant.
  • [F2]Options become exercisable in four equal annual installments beginning one year after date of grant and are fully exercisable three years prior to expiration.
  • [F3]25% of the total options granted became exercisable one year after date of grant. The remaining 75% become exercisable in December 2005.
  • [F4]Options become exercisable in four equal annual installments beginning one year after date of grant and are fully exercisable six years prior to expiration

Issuer

ERESEARCHTECHNOLOGY INC /DE/

CIK 0001026650

Entity typeother

Related Parties

1
  • filerCIK 0001381040

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 5:53 PM ET
Size
19.7 KB